Cash & equivalents decreased 38.4%
Cash & equivalents changed -38.4% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -38.4% from the comparable as-filed period.
Gross margin changed -352 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Gross profit changed -30.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Inventory changed -21.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Net income changed -70.0% from the comparable as-filed period.
Operating income changed -76.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed -2265 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Revenue changed -24.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Stock-based compensation changed -22.0% from the comparable as-filed period.
Research & development changed -4.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.